Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions

NCT01621750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Clopidogrel

Sponsor

Dr. Reddy's Laboratories Limited